JPWO2022117477A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022117477A5 JPWO2022117477A5 JP2023527318A JP2023527318A JPWO2022117477A5 JP WO2022117477 A5 JPWO2022117477 A5 JP WO2022117477A5 JP 2023527318 A JP2023527318 A JP 2023527318A JP 2023527318 A JP2023527318 A JP 2023527318A JP WO2022117477 A5 JPWO2022117477 A5 JP WO2022117477A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- compound according
- hydroxymethyl
- indazol
- thiazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20210859 | 2020-12-01 | ||
| EP20210859.3 | 2020-12-01 | ||
| PCT/EP2021/083279 WO2022117477A1 (en) | 2020-12-01 | 2021-11-29 | New indazole acetylene derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023550902A JP2023550902A (ja) | 2023-12-06 |
| JP2023550902A5 JP2023550902A5 (https=) | 2024-12-04 |
| JPWO2022117477A5 true JPWO2022117477A5 (https=) | 2024-12-04 |
| JP7840327B2 JP7840327B2 (ja) | 2026-04-03 |
Family
ID=73654642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527318A Active JP7840327B2 (ja) | 2020-12-01 | 2021-11-29 | 新規インダゾールアセチレン誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240002390A1 (https=) |
| EP (1) | EP4255908A1 (https=) |
| JP (1) | JP7840327B2 (https=) |
| KR (1) | KR20230116799A (https=) |
| CN (1) | CN116490182A (https=) |
| AR (1) | AR124170A1 (https=) |
| AU (1) | AU2021393722A1 (https=) |
| CA (1) | CA3197659A1 (https=) |
| CL (1) | CL2023001440A1 (https=) |
| CO (1) | CO2023006912A2 (https=) |
| CR (1) | CR20230218A (https=) |
| IL (1) | IL303064A (https=) |
| MX (1) | MX2023006176A (https=) |
| PE (1) | PE20240099A1 (https=) |
| WO (1) | WO2022117477A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114008049B (zh) | 2019-06-21 | 2024-07-05 | 豪夫迈·罗氏有限公司 | 用于癌症治疗的egfr抑制剂 |
| JP7840324B2 (ja) | 2020-12-01 | 2026-04-03 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 新規インダゾール誘導体 |
| JP2025516543A (ja) * | 2022-05-13 | 2025-05-30 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | がんの治療のためのアロステリックおよびオルソステリックｅｇｆｒ阻害剤の組み合わせ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2987914C (en) * | 2015-06-30 | 2022-09-13 | Dana-Farber Cancer Institute, Inc. | Inhibitors of egfr and methods of use thereof |
| TW201834651A (zh) * | 2016-12-22 | 2018-10-01 | 瑞士商赫孚孟拉羅股份公司 | 化合物 |
| WO2018220149A1 (en) * | 2017-06-02 | 2018-12-06 | F. Hoffmann-La Roche Ag | Compounds |
| SG11202011818YA (en) * | 2018-06-29 | 2020-12-30 | Hoffmann La Roche | Compounds |
| CN113993591A (zh) * | 2019-06-21 | 2022-01-28 | 豪夫迈·罗氏有限公司 | 新egfr抑制剂 |
-
2021
- 2021-11-29 PE PE2023001615A patent/PE20240099A1/es unknown
- 2021-11-29 WO PCT/EP2021/083279 patent/WO2022117477A1/en not_active Ceased
- 2021-11-29 AU AU2021393722A patent/AU2021393722A1/en active Pending
- 2021-11-29 KR KR1020237018340A patent/KR20230116799A/ko active Pending
- 2021-11-29 CN CN202180079840.XA patent/CN116490182A/zh active Pending
- 2021-11-29 MX MX2023006176A patent/MX2023006176A/es unknown
- 2021-11-29 US US18/255,083 patent/US20240002390A1/en active Pending
- 2021-11-29 AR ARP210103288A patent/AR124170A1/es not_active Application Discontinuation
- 2021-11-29 EP EP21816073.7A patent/EP4255908A1/en active Pending
- 2021-11-29 IL IL303064A patent/IL303064A/en unknown
- 2021-11-29 JP JP2023527318A patent/JP7840327B2/ja active Active
- 2021-11-29 CA CA3197659A patent/CA3197659A1/en active Pending
- 2021-11-29 CR CR20230218A patent/CR20230218A/es unknown
-
2023
- 2023-05-18 CL CL2023001440A patent/CL2023001440A1/es unknown
- 2023-05-26 CO CONC2023/0006912A patent/CO2023006912A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220241261A1 (en) | Combinations of inhibitors of irak4 with inhibitors of btk | |
| JP5450434B2 (ja) | 関節炎の治療方法 | |
| JP2020510015A5 (https=) | ||
| JP2014513110A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2011509309A5 (https=) | ||
| JP2011500758A5 (https=) | ||
| CN105308036A (zh) | 用于激酶调节的化合物和方法及其适应症 | |
| JP2022017461A5 (https=) | ||
| JP2018534288A5 (https=) | ||
| JPWO2023064857A5 (https=) | ||
| JP2005538099A5 (https=) | ||
| JP2019505595A5 (https=) | ||
| US20190105309A1 (en) | Formylated N-heterocyclic derivatives as FGFR4 inhibitors. | |
| JP2025529629A (ja) | 腫瘍の処置における放射線治療と組み合わせたイミダゾリノン誘導体の使用 | |
| WO2019224774A1 (en) | Heterocyclic amides as rip1 kinase inhibitors | |
| JPWO2022235558A5 (https=) | ||
| JP2013522372A5 (https=) | ||
| JPWO2022117477A5 (https=) | ||
| JP2018522037A5 (https=) | ||
| JP2007514790A5 (https=) | ||
| JPWO2020132016A5 (https=) | ||
| JPWO2022254371A5 (https=) | ||
| JPWO2021207453A5 (https=) | ||
| JP2004538313A5 (https=) |